View source for 18749828. NOVEL CYCLOPROPYL COMPOUNDS simplified abstract (HOFFMANN-LA ROCHE INC.)

=NOVEL CYCLOPROPYL COMPOUNDS=


==Organization Name==

[[:Category:HOFFMANN-LA ROCHE INC.|HOFFMANN-LA ROCHE INC.]]


[[Category:HOFFMANN-LA ROCHE INC.]]

==Inventor(s)==

[[:Category:Mark Chapman of Durham NC (US)|Mark Chapman of Durham NC (US)]][[Category:Mark Chapman of Durham NC (US)]]

[[:Category:Nicholas Gareth Morse Davies of Wokingham (GB)|Nicholas Gareth Morse Davies of Wokingham (GB)]][[Category:Nicholas Gareth Morse Davies of Wokingham (GB)]]

[[:Category:Aaron Gerlach of Durham NC (US)|Aaron Gerlach of Durham NC (US)]][[Category:Aaron Gerlach of Durham NC (US)]]

[[:Category:Christopher John Graham of Durham NC (US)|Christopher John Graham of Durham NC (US)]][[Category:Christopher John Graham of Durham NC (US)]]

[[:Category:Sylvain Lebreton of Durham NC (US)|Sylvain Lebreton of Durham NC (US)]][[Category:Sylvain Lebreton of Durham NC (US)]]

[[:Category:Ronghua Li of Tucson AZ (US)|Ronghua Li of Tucson AZ (US)]][[Category:Ronghua Li of Tucson AZ (US)]]

[[:Category:Nina Ma of Durham NC (US)|Nina Ma of Durham NC (US)]][[Category:Nina Ma of Durham NC (US)]]

[[:Category:Daniel Maddox of Durham NC (US)|Daniel Maddox of Durham NC (US)]][[Category:Daniel Maddox of Durham NC (US)]]

[[:Category:Ingrid Mechin of Durham NC (US)|Ingrid Mechin of Durham NC (US)]][[Category:Ingrid Mechin of Durham NC (US)]]

[[:Category:David Mowrey of Durham NC (US)|David Mowrey of Durham NC (US)]][[Category:David Mowrey of Durham NC (US)]]

[[:Category:Karthigeyan Nagarajan of Durham NC (US)|Karthigeyan Nagarajan of Durham NC (US)]][[Category:Karthigeyan Nagarajan of Durham NC (US)]]

[[:Category:Anil Nair of Durham NC (US)|Anil Nair of Durham NC (US)]][[Category:Anil Nair of Durham NC (US)]]

[[:Category:Roger David Norcross of Aargau (CH)|Roger David Norcross of Aargau (CH)]][[Category:Roger David Norcross of Aargau (CH)]]

[[:Category:Roger Lluis Redondo Pena of Basel (CH)|Roger Lluis Redondo Pena of Basel (CH)]][[Category:Roger Lluis Redondo Pena of Basel (CH)]]

[[:Category:Alena Safarova of Durham NC (US)|Alena Safarova of Durham NC (US)]][[Category:Alena Safarova of Durham NC (US)]]

[[:Category:Martin Smrcina of Durham NC (US)|Martin Smrcina of Durham NC (US)]][[Category:Martin Smrcina of Durham NC (US)]]

==NOVEL CYCLOPROPYL COMPOUNDS - A simplified explanation of the abstract==


This abstract first appeared for US patent application 18749828 titled 'NOVEL CYCLOPROPYL COMPOUNDS

The invention provides new heterocyclic compounds having the general formula (I′), or a solvate or a pharmaceutically acceptable salt thereof.

* These new heterocyclic compounds have the general formula (I′).
* The compounds can exist as solvates or pharmaceutically acceptable salts.
* The invention opens up possibilities for new pharmaceutical agents or treatments.
* The compounds may have unique properties or activities that make them valuable for various applications.
* The invention may lead to the development of novel drugs or therapies in the medical field.

Potential Applications:
These compounds could be used in the development of new pharmaceutical drugs or treatments.
They may have applications in the treatment of specific diseases or conditions.
The compounds could be utilized in research settings for further exploration of their properties and potential uses.

Problems Solved:
The invention addresses the need for new and potentially more effective pharmaceutical compounds.
It provides a novel approach to drug discovery and development.
The compounds may offer solutions to existing challenges in the medical field.

Benefits:
The compounds offer the potential for new and improved pharmaceutical options.
They may lead to advancements in medical treatment and patient care.
The invention could have a positive impact on the pharmaceutical industry and healthcare overall.

Commercial Applications:
The compounds could be developed into marketable pharmaceutical products.
They may attract interest from pharmaceutical companies looking to expand their product pipelines.
The invention could have implications for the market competitiveness of companies in the pharmaceutical sector.

Questions about the technology:
1. How do these new heterocyclic compounds differ from existing pharmaceutical compounds?
2. What specific medical conditions or diseases could potentially be treated using these compounds?

Frequently Updated Research:
Researchers may continue to explore the properties and potential applications of these heterocyclic compounds.
New studies could reveal additional benefits or uses for the compounds in various medical contexts.


==Original Abstract Submitted==

The invention provides new heterocyclic compounds having the general formula (I′), or a solvate or a pharmaceutically acceptable salt thereof:



[[Category:C07D221/00]]
[[Category:A61K31/4433]]
[[Category:A61K31/4439]]
[[Category:C07D239/26]]
[[Category:C07D401/04]]
[[Category:C07D405/12]]
[[Category:C07D413/04]]
[[Category:C07D417/04]]
[[Category:CPC_C07D221/00]]